Literature DB >> 17072458

Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis.

Luciano Mengatto1, Yosena Chiani, María Susana Imaz.   

Abstract

A study was carried out to compare the performance of a commercial method (MGIT) and four inexpensive drug susceptibility methods: nitrate reductase assay (NRA), microscopic observation drug susceptibility (MODS) assay, MTT test, and broth microdilution method (BMM). A total of 64 clinical isolates of Mycobacterium tuberculosis were studied. The Lowenstein-Jensen proportion method (PM) was used as gold standard. MGIT NRA, MODS, and MTT results were available on an average of less than 10 days, whereas BMM results could be reported in about 20 days. Most of the evaluated tests showed excellent performance for isoniazid and rifampicin, with sensitivity and specificity values > 90%. With most of the assays, sensitivity for ethambutol was low (62-87%) whereas for streptomycin, sensitivity values ranged from 84 to 100%; NRA-discrepancies were associated with cultures with a low proportion of EMB-resistant organisms while most discrepancies with quantitative tests (MMT and BMM) were seen with isolates whose minimal inhibitory concentrations fell close the cutoff MGIT is reliable but still expensive. NRA is the most inexpensive and easiest method to perform without changing the organization of the routine PM laboratory performance. While MODS, MTT, and BMM, have the disadvantage from the point of view of biosafety, they offer the possibility of detecting partial resistant strains. This study shows a very good level of agreement of the four low-cost methods compared to the PM for rapid detection of isoniazid, rifampicin and streptomycin resistance (Kappa values > 0.8); more standardization is needed for ethambutol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072458     DOI: 10.1590/s0074-02762006000500009

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  12 in total

1.  Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Niuris C Mirabal; Sergio L Yzquierdo; Dihadenys Lemus; Mariela Madruga; Yoslaine Milián; Miguel Echemendía; Howard Takiff; Anandi Martin; Patrick Van der Stuyf; Juan Carlos Palomino; Ernesto Montoro
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

2.  MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus.

Authors:  J Coronel; M Roper; S Mitchell; E Castillo; N Gamarra; F Drobniewski; G Luna; A Mendoza; D A J Moore
Journal:  Int J Tuberc Lung Dis       Date:  2010-11       Impact factor: 2.373

3.  Programmatic implementation of rapid DST for Mycobacterium tuberculosis in Peru.

Authors:  L Asencios; G Yale; M Yagui; N Quispe; A Taylor; J Blaya; C Contreras; P Cegielski; J Bayona; C Bonilla; S Shin
Journal:  Int J Tuberc Lung Dis       Date:  2008-07       Impact factor: 2.373

4.  Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles.

Authors:  S Dhanasekaran; S Jenum; R Stavrum; C Ritz; J Kenneth; M Vaz; T M Doherty; H M S Grewal
Journal:  Genes Immun       Date:  2014-04-17       Impact factor: 2.676

5.  Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex.

Authors:  K G P Hoek; N C Gey van Pittius; H Moolman-Smook; K Carelse-Tofa; A Jordaan; G D van der Spuy; E Streicher; T C Victor; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

6.  Evaluation of Microscopic observation drug susceptibility (MODS) assay as a rapid, sensitive and inexpensive test for detection of tuberculosis and multidrug resistant tuberculosis.

Authors:  A Agarwal; C D S Katoch; M Kumar; T N Dhole; Y K Sharma
Journal:  Med J Armed Forces India       Date:  2018-05-28

7.  Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey.

Authors:  David J Horne; Monica Campo; Justin R Ortiz; Eyal Oren; Matthew Arentz; Kristina Crothers; Masahiro Narita
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

8.  Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs.

Authors:  Marcelo Miyata; Fernando Rogério Pavan; Daisy Nakamura Sato; Leonardo Biancolino Marino; Mario Hiroyuki Hirata; Rosilene Fressati Cardoso; Fernando Augusto Fiúza de Melo; Clarice Queico Fujimura Leite
Journal:  Braz J Microbiol       Date:  2013-05-14       Impact factor: 2.476

9.  Effect of non-tuberculous Mycobacteria on host biomarkers potentially relevant for tuberculosis management.

Authors:  S Dhanasekaran; Synne Jenum; Ruth Stavrum; Harald G Wiker; John Kenneth; Mario Vaz; T Mark Doherty; Harleen M S Grewal
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

10.  Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs.

Authors:  Karine O Sanchotene; Andrea von Groll; Daniela Ramos; Ana B Scholante; Gunther Honscha; Mariana Valença; Carlos J Scaini; Pedro E A da Silva
Journal:  Braz J Microbiol       Date:  2008-03-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.